Neurocrine Biosciences | Handelsfordringar



Trade Debtors Ändra Datum
AbbVie USD 10.92B 553M 2024-12
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 3.34M 765K 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Cytokinetics USD 16.65M 16.41M 2024-12
Dynavax Technologies USD 46.91M 28.37M 2024-12
Exelixis USD 265.44M 4.27M 2025-01
Gilead Sciences USD 4.39B 32M 2025-03
Halozyme Therapeutics USD 308.46M 22.71M 2024-12
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Repligen USD 147.41M 13.3M 2025-03
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Teva Pharmaceutical Industries USD 3.06B 403M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Neurocrine Biosciences Handelsfordringar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.